203 related articles for article (PubMed ID: 38118409)
1. Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7.
Jin X; Liu D; Zhou X; Luo X; Huang Q; Huang Y
Cell Rep Med; 2023 Dec; 4(12):101310. PubMed ID: 38118409
[TBL] [Abstract][Full Text] [Related]
2. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction.
Li Q; Feng H; Wang H; Wang Y; Mou W; Xu G; Zhang P; Li R; Shi W; Wang Z; Fang Z; Ren L; Wang Y; Lin L; Hou X; Dai W; Li Z; Wei Z; Liu T; Wang J; Guo Y; Li P; Zhao X; Zhan X; Xiao X; Bai Z
EMBO Rep; 2022 Feb; 23(2):e53499. PubMed ID: 34882936
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of artemisinin on uric acid-induced NLRP3 inflammasome activation through blocking interaction between NLRP3 and NEK7.
Kim SK; Choe JY; Park KY
Biochem Biophys Res Commun; 2019 Sep; 517(2):338-345. PubMed ID: 31358323
[TBL] [Abstract][Full Text] [Related]
4. Helenine blocks NLRP3 activation by disrupting the NEK7-NLRP3 interaction and ameliorates inflammatory diseases.
Fang ZE; Wang Y; Bian S; Qin S; Zhao H; Wen J; Liu T; Ren L; Li Q; Shi W; Zhao J; Yang H; Peng R; Wang Q; Bai Z; Xu G
Phytomedicine; 2024 Jan; 122():155159. PubMed ID: 37931457
[TBL] [Abstract][Full Text] [Related]
5. NIMA-related kinase 7 amplifies NLRP3 inflammasome pro-inflammatory signaling in microglia/macrophages and mice models of spinal cord injury.
Ji X; Song Z; He J; Guo S; Chen Y; Wang H; Zhang J; Xu X; Liu J
Exp Cell Res; 2021 Jan; 398(2):112418. PubMed ID: 33309808
[TBL] [Abstract][Full Text] [Related]
6. A Single Amino Acid Residue Defines the Difference in NLRP3 Inflammasome Activation between NEK7 and NEK6.
Jeltema D; Wang J; Cai J; Kelley N; Yang Z; He Y
J Immunol; 2022 Apr; 208(8):2029-2036. PubMed ID: 35354613
[TBL] [Abstract][Full Text] [Related]
7. NEK7: a potential therapy target for NLRP3-related diseases.
Liu G; Chen X; Wang Q; Yuan L
Biosci Trends; 2020 May; 14(2):74-82. PubMed ID: 32295992
[TBL] [Abstract][Full Text] [Related]
8. PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.
Yang XD; Li W; Zhang S; Wu D; Jiang X; Tan R; Niu X; Wang Q; Wu X; Liu Z; Chen LF; Qin J; Su B
EMBO J; 2020 Jan; 39(2):e102201. PubMed ID: 31762063
[TBL] [Abstract][Full Text] [Related]
9. NEK7 mediated assembly and activation of NLRP3 inflammasome downstream of potassium efflux in ventilator-induced lung injury.
Liu H; Gu C; Liu M; Liu G; Wang Y
Biochem Pharmacol; 2020 Jul; 177():113998. PubMed ID: 32353421
[TBL] [Abstract][Full Text] [Related]
10. HECTD3 inhibits NLRP3 inflammasome assembly and activation by blocking NLRP3-NEK7 interaction.
Cheng Z; Huang M; Li W; Hou L; Jin L; Fan Q; Zhang L; Li C; Zeng L; Yang C; Liang B; Li F; Chen C
Cell Death Dis; 2024 Jan; 15(1):86. PubMed ID: 38267403
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.
Zhao N; Li CC; Di B; Xu LL
J Autoimmun; 2020 Sep; 113():102515. PubMed ID: 32703754
[TBL] [Abstract][Full Text] [Related]
12. NEK7-Mediated Activation of NLRP3 Inflammasome Is Coordinated by Potassium Efflux/Syk/JNK Signaling During
Liu R; Liu Y; Liu C; Gao A; Wang L; Tang H; Wu Q; Wang X; Tian D; Qi Z; Shen Y
Front Immunol; 2021; 12():747370. PubMed ID: 34603335
[No Abstract] [Full Text] [Related]
13. Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7.
Yu J; Li H; Wu Y; Luo M; Chen S; Shen G; Wei X; Shao B
Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2316551121. PubMed ID: 38865260
[TBL] [Abstract][Full Text] [Related]
14. RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor.
Chen Y; He H; Lin B; Chen Y; Deng X; Jiang W; Zhou R
Cell Mol Immunol; 2021 Jun; 18(6):1425-1436. PubMed ID: 33972740
[TBL] [Abstract][Full Text] [Related]
15. Glutathione Transferase Omega-1 Regulates NLRP3 Inflammasome Activation through NEK7 Deglutathionylation.
Hughes MM; Hooftman A; Angiari S; Tummala P; Zaslona Z; Runtsch MC; McGettrick AF; Sutton CE; Diskin C; Rooke M; Takahashi S; Sundararaj S; Casarotto MG; Dahlstrom JE; Palsson-McDermott EM; Corr SC; Mills KHG; Preston RJS; Neamati N; Xie Y; Baell JB; Board PG; O'Neill LAJ
Cell Rep; 2019 Oct; 29(1):151-161.e5. PubMed ID: 31577945
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200c-5p targets NIMA Related Kinase 7 (NEK7) to inhibit NOD-like receptor 3 (NLRP3) inflammasome activation, MODE-K cell pyroptosis, and inflammatory bowel disease in mice.
Wu G; Zhang D; Yang L; Wu Q; Yuan L
Mol Immunol; 2022 Jun; 146():57-68. PubMed ID: 35447415
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of NEK7 alleviates anterior cruciate ligament transection osteoarthritis (ACLT)-induced knee osteoarthritis in mice via inhibiting NLRP3 activation.
Sun W; Yue M; Xi G; Wang K; Sai J
Autoimmunity; 2022 Sep; 55(6):398-407. PubMed ID: 35798413
[TBL] [Abstract][Full Text] [Related]
18. A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout.
Park K; Shin I; Kim Y; Kang H; Oh SJ; Jang E; Sim T; Youn J; Lee MS
Front Immunol; 2023; 14():1307739. PubMed ID: 38371945
[TBL] [Abstract][Full Text] [Related]
19. Oridonin ameliorates noise-induced hearing loss by blocking NLRP3 - NEK7 mediated inflammasome activation.
Li M; Zhang Y; Qiu S; Zhuang W; Jiang W; Wang C; Zhang S; Zhou Z; Sun T; Ke Z; Guo W; Qiao Y; Shi X
Int Immunopharmacol; 2021 Jun; 95():107576. PubMed ID: 33770730
[TBL] [Abstract][Full Text] [Related]
20. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.
He Y; Zeng MY; Yang D; Motro B; Núñez G
Nature; 2016 Feb; 530(7590):354-7. PubMed ID: 26814970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
